Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Stephen P. Carey

CFO at Ani Pharmaceuticals Inc (ANIP)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.0M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 30SEC ANIPAni Pharmaceuticals Inc Sell Plan 2,850168,993 held (−2%) $73.00 $208K +1.2%
Sep 1SEC ANIPAni Pharmaceuticals Inc Sell Plan 2,850171,843 held (−2%) $72.80 $207K +1.5%
Jul 30SEC ANIPAni Pharmaceuticals Inc Sell Plan 2,850174,693 held (−2%) $81.36 $232K -9.2%
Jul 6SEC ANIPAni Pharmaceuticals Inc Sell Plan 3,313177,543 held (−2%) $86.00 $285K -14.1%
Jun 30SEC ANIPAni Pharmaceuticals Inc Sell Plan 2,850177,543 held (−2%) $84.12 $240K -12.2%
Jun 9SEC ANIPAni Pharmaceuticals Inc Sell Plan 3,312180,393 held (−2%) $80.00 $265K -7.6%
Mar 5SEC ANIPAni Pharmaceuticals Inc Sell 3,312189,543 held (−2%) $75.42 $250K -2.0%
Mar 5SEC ANIPAni Pharmaceuticals Inc Sell 4,000185,543 held (−2%) $75.56 $302K -2.2%
  • Sell

    CFO Stephen P. Carey sold $208K of ANIP at $73.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Stephen P. Carey sold $207K of ANIP at $72.80 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Stephen P. Carey sold $232K of ANIP at $81.36 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Stephen P. Carey sold $285K of ANIP at $86.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Stephen P. Carey sold $240K of ANIP at $84.12 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Stephen P. Carey sold $265K of ANIP at $80.00 — pre-scheduled 10b5-1 plan sale.